Accolade rises after two brokerages raise PT

Accolade

04/10/2022 15:35

** Shares of tech-based healthcare systems provider Accolade
 ACCD.O  climb ~8% to $12.70 after at least two brokerages raise
price targets 
    ** Piper Sandler raises PT to $13 from $12, says enterprise
customers value co's navigation product despite broader market
conditions
    ** Brokerage also positive on co's diversification through
Expert Medical Opinion and PlushCare acquisition; adds that it
de-risks revenue which still has navigation contribute
two-thirds
    ** Needham raises PT to $15 from $12, and is confident on
expansion of co's healthcare assets
    ** Brokerage also sees a robust selling season in healthcare
navigation systems market 
    ** 10 of 17 brokerages rate the stock "buy" or higher, 7
"hold"; median PT is $13 - Refinitiv data
    ** YTD, the stock has fallen ~52% 
 (Reporting by Anirban Chakroborti in Bengaluru)
 ((Anirban.Chakroborti@thomsonreuters.com;))